<DOC>
	<DOCNO>NCT00046722</DOCNO>
	<brief_summary>To evaluate whether smoked marijuana reduces pain people HIV-related peripheral neuropathy .</brief_summary>
	<brief_title>Marijuana HIV-Related Peripheral Neuropathy</brief_title>
	<detailed_description>The study include subject peripheral neuropathy cause either HIV-disease antiretroviral medication treatment HIV . A neurologist conduct neurological pain evaluation determine eligibility study . Subjects meet eligibility criterion admit General Clinical Research Center San Francisco General Hospital seven day . Subjects randomize ( like toss coin ) smoke marijuana placebo ( cigarette THC ) .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<criteria>INCLUSION CRITERIA : HIV positive . Be 18 year old . Diagnosis HIVrelated painful neuropathy . Stable antiretroviral therapy antiretroviral therapy least 8 week . Prior use marijuana , least 6 occasion lifetime prior enrollment . EXCLUSION CRITERIA : ( Not allow ) Current use smoke tobacco product . Current methadone treatment . Use smoke marijuana within 30 day enrollment . Diagnosis diabetes mellitus . Currently receive treatment corticosteroid . Use INH , dapsone metronidazole within 8 week prior enrollment . Severe heart disease , uncontrolled high blood pressure lung disease . Women pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>treatment experience</keyword>
	<keyword>complementary therapy</keyword>
	<keyword>Neuropathy</keyword>
	<keyword>Peripheral Neuropathy</keyword>
	<keyword>HIV-Related Peripheral Neuropathy</keyword>
	<keyword>HIV</keyword>
</DOC>